Part D – Page 5 – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part D

Part D

Showing 41 - 50 out of 334

Mar 15, 2022 / Chapters

Appendix A: Commissioners’ voting on recommendations (March 2022 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 04, 2022 / Comment Letters

MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 03, 2022 / Presentations

Medicare payment policies to support safety-net providers

Research Areas:

Hospitals

Feb 02, 2022 / Congressional Testimony

Testimony: The Hospital Insurance Trust Fund and the Future of Medicare Financing (Senate Finance)

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans, Quality

Jan 13, 2022 / Transcripts

January 2022 meeting transcript

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Nov 09, 2021 / Presentations

Part D for residents in long-term care facilities

Research Areas:

Drugs, Devices, and Tests, Hospitals, Post-Acute Care

Oct 07, 2021 / Presentations

Addressing high prices of pharmaceutical products (and other technologies) covered under Medicare

Research Areas:

Drugs, Devices, and Tests

Oct 07, 2021 / Presentations

Data on Medicare’s net prices for prescription drugs and other drug pricing metrics

Research Areas:

Drugs, Devices, and Tests